Comparative Effectiveness of Anti-IL5/5R Versus Anti-IgE in Patients Eligible for Both (FIRE)

N. Ali; J.  Lyu; A.  Newell; M. Sadatsafavi; T. N.  Tran; D.B. Price

Comparative Effectiveness of Anti-IL5/5R Versus Anti-IgE in Patients Eligible for Both (FIRE)

N. Ali, J. Lyu, A. Newell, M. Sadatsafavi, T. N. Tran, D.B. Price

Research output: Contribution to conference › Abstract › peer-review

Abstract

The comparative effectiveness of anti-IL5/5R versus anti-IgE among severe asthma patients is unknown.

Original language	English
Publication status	Accepted/In press - 30 Jul 2021
Event	ERS International Congress 2021 - Virtual event Duration: 5 Sept 2021 → 8 Sept 2021 https://www.ersnet.org/congress-and-events/congress/

Conference

Conference	ERS International Congress 2021
Abbreviated title	ERS
Period	5/09/21 → 8/09/21
Internet address	https://www.ersnet.org/congress-and-events/congress/

Keywords

Asthma
management
Severe asthma
Treatments

Cite this

@conference{a9f5d71746cf4c06a8c8faa94287339a,

title = "Comparative Effectiveness of Anti-IL5/5R Versus Anti-IgE in Patients Eligible for Both (FIRE)",

abstract = "The comparative effectiveness of anti-IL5/5R versus anti-IgE among severe asthma patients is unknown.",

keywords = "Asthma, management, Severe asthma, Treatments",

author = "N. Ali and J. Lyu and A. Newell and M. Sadatsafavi and Tran, {T. N.} and D.B. Price",

year = "2021",

month = jul,

day = "30",

language = "English",

note = "ERS International Congress 2021, ERS ; Conference date: 05-09-2021 Through 08-09-2021",

url = "https://www.ersnet.org/congress-and-events/congress/",

}

TY - CONF

T1 - Comparative Effectiveness of Anti-IL5/5R Versus Anti-IgE in Patients Eligible for Both (FIRE)

AU - Ali, N.

AU - Lyu, J.

AU - Newell, A.

AU - Sadatsafavi, M.

AU - Tran, T. N.

AU - Price, D.B.

PY - 2021/7/30

Y1 - 2021/7/30

N2 - The comparative effectiveness of anti-IL5/5R versus anti-IgE among severe asthma patients is unknown.

AB - The comparative effectiveness of anti-IL5/5R versus anti-IgE among severe asthma patients is unknown.

KW - Asthma

KW - management

KW - Severe asthma

KW - Treatments

M3 - Abstract

T2 - ERS International Congress 2021

Y2 - 5 September 2021 through 8 September 2021

ER -

Comparative Effectiveness of Anti-IL5/5R Versus Anti-IgE in Patients Eligible for Both (FIRE)

Abstract

Conference

Keywords

Fingerprint

Cite this